Neurofibromatosis-Noonan syndrome (NFNS) is a clinical entity possessing traits of autosomal dominant disorders neurofibromatosis type 1 (NF1) and Noonan syndrome (NS). Germline mutations that disrupt the RAS/MAPK pathway are involved in the pathogenesis of both NS and NF1. In light of a studied Greek family, a new theory for etiological pathogenesis of NFNS is suggested. The NFNS phenotype may be the final result of a combination of a genetic factor (a mutation in the NF1 gene) and an environmental factor with the epigenetic effects of muscle hypotonia (such as hydantoin in the reported Greek family), causing hypoplasia of the face and micrognathia.
CITATION STYLE
Yapijakis, C., Pachis, N., & Voumvourakis, C. (2017). Neurofibromatosis-noonan syndrome: A possible paradigm of the combination of genetic and epigenetic factors. In Advances in Experimental Medicine and Biology (Vol. 987, pp. 151–159). Springer New York LLC. https://doi.org/10.1007/978-3-319-57379-3_14
Mendeley helps you to discover research relevant for your work.